Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -794 | -13,812 | -11,378 | -7,842 | -3,958 |
| Depreciation Amortization | 2 | 9 | 7 | 5 | 3 |
| Other Working Capital | -274 | 2,036 | 590 | 348 | 12 |
| Other Operating Activity | 184 | 835 | 642 | 446 | 240 |
| Operating Cash Flow | $-882 | $-10,932 | $-10,139 | $-7,043 | $-3,703 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 8,512 | 8,512 | 8,512 | 6,209 |
| Investing Cash Flow | $N/A | $8,512 | $8,512 | $8,512 | $6,209 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 1,115 | 3,535 | 3,535 | 3,535 | 3,535 |
| End Cash Position | 233 | 1,115 | 1,908 | 5,004 | 6,041 |
| Net Cash Flow | $-882 | $-2,420 | $-1,627 | $1,469 | $2,506 |
| Free Cash Flow | |||||
| Operating Cash Flow | -882 | -10,932 | -10,139 | -7,043 | -3,703 |
| Free Cash Flow | -882 | -10,932 | -10,139 | -7,043 | -3,703 |